Efficacy and safety of dendritic cells co-cultured with cytokine-induced killer cells immunotherapy for non-small-cell lung cancer-Reference-Cited by-同舟云学术

Efficacy and safety of dendritic cells co-cultured with cytokine-induced killer cells immunotherapy for non-small-cell lung cancer

Published:2015-09 Issue:1 Volume:28 Page:22-28
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Wang Shuai,Wang Zhou

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference38 articles.

1. Cancer statistics;Siegel;CA Cancer J. Clin.,2012

2. Non-small-cell lung cancer;Goldstraw;Lancet,2011

3. Anaplastic lymphoma kinase inhibition in non small-cell lung cancer;Kwak;N. Engl. J. Med.,2010

4. New driver mutations in non-small-cell lung cancer;Pao;Lancet Oncol.,2011

5. EGFR mutations in patients with non-small cell lung cancer from mainland China and their relationships with clinicopathological features: a meta- analysis;Wang;Int. J. Clin. Exp. Med.,2014

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neoantigen Identification and Dendritic Cell-Based Vaccines for Lung Cancer Immunotherapy;Vaccines;2024-05-05

2. Natural polysaccharides exert anti-tumor effects as dendritic cell immune enhancers;Frontiers in Oncology;2023-10-09

3. Dendritic Cells and Cancer Immunotherapy: The Adjuvant Effect;International Journal of Molecular Sciences;2021-11-15

4. CCL17 and CCL22 induce CCR4 receptor expression and promote cytokine-induced killer cells migration;Anti-Cancer Drugs;2021-10-15

5. Dendritic Cell-Based Immunotherapy in Lung Cancer;Frontiers in Immunology;2021-02-12